NewsBenzingaKORU Medical Systems alza le previsioni di vendita per l’esercizio 2026 da 47,500 milioni di dollari–48,500 milioni di dollari a 48,000 milioni di dollari–48,500 milioni di dollari contro una stima di 48,030 milioni di dollari KORU Medical Systems alza le previsioni di vendita per l’esercizio 2026 da 47,500 milioni di dollari–48,500 milioni di dollari a 48,000 milioni di dollari–48,500 milioni di dollari contro una stima di 48,030 milioni di dollari Benzinga 2026.11.10 21:14 (GMT+0) Open on Benzinga Other news Global-E Online Stock Is Falling Wednesday: What's Going On? Grifols Presents New Real-World Evidence Data From AMBAR Program, Contributing To Ongoing Research Evaluating Use Of TPE With Albumin Replacement In Patients With Alzheimer’s Disease HC Wainwright & Co. Maintains Buy on LifeMD, Lowers Price Target to $6 Stifel Maintains Buy on Ecolab, Raises Price Target to $356 Stifel Upgrades Tandem Diabetes Care to Buy, Raises Price Target to $26 Immuneering Presents Preclinical Data Demonstrating Potential Of Atebimetinib; Phase 2 Results Include Long Survival And Outstanding Tolerability Profile In First-Line Pancreatic Cancer Patients
Grifols Presents New Real-World Evidence Data From AMBAR Program, Contributing To Ongoing Research Evaluating Use Of TPE With Albumin Replacement In Patients With Alzheimer’s Disease
Immuneering Presents Preclinical Data Demonstrating Potential Of Atebimetinib; Phase 2 Results Include Long Survival And Outstanding Tolerability Profile In First-Line Pancreatic Cancer Patients